Resolvyx Pharmaceuticals

Resolvyx Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development and commercialization of resolvins, a novel class of therapies to treat inflammatory diseases and their complications. Resolvyx’s drug R&D programs are focused on characterizing and developing resolvin-based compounds. Resolvyx currently has two programs in clinical development.


Company Profile

Resolvyx Pharmaceuticals Logo
  • Founded: 2005

Flagship Partners:

  • Doug Cole, Managing Partner